Karius

Karius

Redwood City, CA, USA
3 employees
Artificial Intelligence (AI)
Series C · $315M

About Karius

Karius is a life sciences company focused on generating genomic insights for infectious diseases with a liquid biopsy for infectious diseases. The Karius Test helps clinicians make rapid treatment decisions. By mapping each patient’s microbial landscape from a single blood draw, Karius moves closer to a vision of a world where infectious disease is no longer a major threat to human health. The Karius laboratory is CLIA-certified and CAP-accredited to perform high-complexity clinical laboratory testing.

Open positions (9)

Company details

Team Size3
LocationRedwood City, CA, USA
IndustryArtificial Intelligence (AI)

Funding

Total raised

$315M

Last stage

Series C

Investors

Khosla Ventures
55AM Ventures
GGilde Healthcare
Softbank Vision Fund 2
General Catalyst

Founders

Mickey Kertesz

Mickey Kertesz

Co-founded Karius in 2014, building on pathogen detection technology developed at Stanford. Previously CEO and co-founder of Moleculo (acquired by Illumina). PhD in computational biology from Weizmann Institute of Science; postdoctoral work in bioengineering at Stanford.

LinkedIn
TB

Tim Blauwkamp

Co-founder and CSO of Karius. Previously Staff Scientist at Illumina and Head of Molecular Biology at Moleculo. Background in chemistry and biochemistry from Grand Valley State University.

SQ

Stephen Quake

Co-founder of Karius. Renowned Stanford professor in bioengineering whose lab developed the foundational microbial cell-free DNA technology underlying the Karius Test.

What happens next.

No applications, no recruiter spam. Just the intro.

01

Confirm the fit

A few questions to make sure this role is the right shape for you. Two minutes.

02

I pitch you to the company

I write the intro, send it to the founder, and handle the back-and-forth.

03

A meeting lands on your calendar

If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.